Skip to content
On this page:OverviewPublicationsResearchersInstitutionsOpen access
PICO Portalanswers from OpenAlex

Johnson & Johnson (Singapore)

InstitutionResearch output, impact & collaborations

Johnson & Johnson (Singapore) is a institution indexed in PICO Portal from OpenAlex.

What is known about Johnson & Johnson (Singapore)?

PICO Portalrecord summary

Johnson & Johnson (Singapore) is a research organisation in Singapore, SG. OpenAlex records 357 works and 9,024 citations for it. 119 researchers list it as their most recent affiliation.

How many works does Johnson & Johnson (Singapore) have?

PICO Portalindexed works

Johnson & Johnson (Singapore) has 357 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Johnson & Johnson (Singapore) have?

PICO Portalcitation count

Johnson & Johnson (Singapore) has 9,024 citations in the OpenAlex counts PICO Portal stores.

How many researchers are at Johnson & Johnson (Singapore)?

PICO Portalresearcher count

Johnson & Johnson (Singapore) has 119 researchers in the PICO Portal index.

What is the average h-index at Johnson & Johnson (Singapore)?

PICO Portalavg h-index

Johnson & Johnson (Singapore) has an average h-index of 3 in OpenAlex.

What is the ROR of Johnson & Johnson (Singapore)?

PICO Portalror

The ROR for Johnson & Johnson (Singapore) is on the source record.

What is the OpenAlex record for Johnson & Johnson (Singapore)?

PICO Portalopenalex

The OpenAlex for Johnson & Johnson (Singapore) is on the source record.

Who are the most-cited researchers behind Johnson & Johnson (Singapore)?

PICO Portaltop researchers by citations
1
Anildeep Singh · Prostate Cancer Treatment and Research
10 works20 citations

What are the most-cited papers on Johnson & Johnson (Singapore)?

PICO Portalmost cited works
Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial
Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhangqun Ye, Hiroyoshi Suzuki, Taek Won Kang, Dalin He, Jae Young Joung, Sabine Brookman‐May, Sharon McCarthy, Amitabha Bhaumik, Anildeep Singh, Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Dingwei Ye, Kim N., Hirotsugu Uemura
Asian Journal of Andrology. 20237 CitationsOPEN ACCESS
Prostate‐specific antigen kinetics in Asian patients with metastatic castration‐sensitive prostate cancer treated with apalutamide in the <scp>TITAN</scp> trial: A post hoc analysis
Dingwei Ye, Hirotsugu Uemura, Byung Ha Chung, Hiroyoshi Suzuki, Suneel Mundle, Amitabha Bhaumik, Anildeep Singh, Simon Chowdhury, Neeraj Agarwal, Kim N., Jian Huang
International Journal of Urology. 20247 Citations
Understanding Experiences and Needs of Patients With Prostate Cancer Across Asia-Pacific: A Cross-Sectional Mixed-Methods Study
Ben Tran, Atsushi Mizokami, Shian‐Shiang Wang, Frank Yonghong Li, Tsutomu Takeuchi, Paul Bain, Yiting Liu, Chan Young Maeng, Anildeep Singh, Naomi Kishiwada, Marie Simone Cheng, Regina Gowindah, Jennifer Si, Hyun Ho Han
JU Open Plus. 20244 CitationsOPEN ACCESS
UFO registry: final analysis of baseline data from patients with advanced prostate cancer in Asia
Dingwei Ye, Ravindran Kanesvaran, Edmund Chiong, Bannakij Lojanapiwat, Yeong‐Shiau Pu, Sudhir Kumar Rawal, Ong Teng Aik, Hao Zeng, Byung Ha Chung, Md Yusoff Noor Ashani, Chikara Οhyama, Choung‐Soo Kim, Zuquan Hu, Yuh‐Shyan Tsai, Azad Hassan Abdul Razack, Anildeep Singh, Yanfang Liu, Hirotsugu Uemura
Therapeutic Advances in Medical Oncology. 20241 CitationsOPEN ACCESS
Efficacy and safety of apalutamide in metastatic castration sensitive prostate cancer patients with a prior history of cardiovascular or metabolic risk factors: A post-hoc analysis of the TITAN study.
Arun Azad, Dingwei Ye, Hiroji Uemura, Amitabha Bhaumik, Michael Eisbacher, Anildeep Singh, Sharon McCarthy, Suneel Mundle, Kim N., Neeraj Agarwal
Journal of Clinical Oncology. 20251 Citations

How much of the research on Johnson & Johnson (Singapore) is open access?

PICO Portalopen access share
40%OPEN ACCESS
Gold
20%
Green
0%
Hybrid
10%
Bronze
10%
Closed
60%

Related on PICO Portal

470M+ articles · 14-day free trial